Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Why Futura Medical (LSE:FUM) Reaches a Key Deadline for Proposals in Its Formal Sale Process

Futura Medical, quoted on AIM since 2003, develops sexual health products based on topically delivered gel formulations. Its lead product is Eroxon, a gel for erectile dysfunction, which is sold in the US through partners and earns royalties. Its pipeline includes Eroxon Intense, which …

Ankur Sharma | 05 October 2026

Bioventix (LSE:BVXP) Shares Climb 2.13% Ahead of Full-Year Results as Alzheimer's Tau Antibody Royalties Accelerate

The shares have had a volatile 12 months, trading in a 52-week range of roughly 1,300p to 3,020p, so the run-up to results is a period when buyers and sellers are particularly active.

Ankur Sharma | 05 October 2026

CelLBxHealth Shares Rise 6.45% as Parsortix Cancer Detection Platform Gains Pharma Traction (LSE:CLBX)

CelLBxHealth's Parsortix platform captures circulating tumour cells, or CTCs, from a simple blood sample. These cells can reveal how a cancer is behaving and responding to treatment, making the technology valuable for research,Drug Developmentand clinical oncology.

Ankur Sharma | 05 October 2026

Diaceutics (LSE:DXRX) Shares Rise 1.83% Near 52-Week High on 38% Order Book Growth and Expanded Syndax Partnership

The continued buying suggests investors increasingly view Diaceutics as a scalable, high-margin data and services platform at an inflection point in recurring revenue.

Ankur Sharma | 05 October 2026

UK Healthcare Stocks to Watch in October: AstraZeneca (LSE:AZN), GSK (LSE:GSK) and Haleon (LSE:HLN) Put Pipelines and Defensive Growth in Focus

• October puts the UK health care sector in focus as investors reassessEarningsresilience against higher gilt yields,Inflationrisk and the approaching UK Budget.

Ankur Sharma | 05 October 2026

Cambridge Nutritional Sciences Plc (LSE:CNSL) Jumps 9.68%: Why the Stock Is in Focus on 2 October 2026

• Cambridge Nutritional Sciences Plc (LSE:CNSL) advanced 9.68% on 2 October 2026, putting the stock among the stronger movers in the session.

Ankur Sharma | 02 October 2026

EDX Medical Group PLC (LSE:EDX) Jumps 8.57%: Why the Stock Is in Focus on 2 October 2026

• EDX Medical Group PLC (LSE:EDX) advanced 8.57% on 2 October 2026, putting the stock among the stronger movers in the session.

Ankur Sharma | 02 October 2026

ValiRx Plc (LSE:VAL) Jumps 11.11%: Why the Stock Is in Focus on 2 October 2026

• ValiRx Plc (LSE:VAL) advanced 11.11% on 2 October 2026, putting the stock among the stronger movers in the session.

Ankur Sharma | 02 October 2026

Verici Dx Plc (LSE:VRCI) Jumps 7.14%: Why the Stock Is in Focus on 2 October 2026

• Verici Dx Plc (LSE:VRCI) advanced 7.14% on 2 October 2026, putting the stock among the stronger movers in the session.

Ankur Sharma | 02 October 2026

Anpario PLC (LSE:ANP) Shares Rise 6.12% as Investors Back 22% EBITDA Growth and Rising Dividend

There was no fresh announcement from the company on the day. Instead, the rally looks like continued investor support following its interim results on 9 September, after the shares had closed at around 490 pence on 30 September.

Ankur Sharma | 02 October 2026
Support

Hi! How can we help you today?

Loading…